[PDF][PDF] Protective effect of resveratrol on knee osteoarthritis and its molecular mechanisms: a recent review in preclinical and clinical trials

S Yang, M Sun, X Zhang - Frontiers in Pharmacology, 2022 - frontiersin.org
Osteoarthritis (OA) is one of the progressing chronic joint associated with by many complex
factors such as age, obesity, and trauma. Knee osteoarthritis (KOA) is the most common type …

Disease-associated regulation of non-coding RNAs by resveratrol: molecular insights and therapeutic applications

R Giordo, Z Wehbe, AM Posadino, GL Erre… - Frontiers in Cell and …, 2022 - frontiersin.org
There have been significant advances, particularly over the last 20 years, in the identification
of non-coding RNAs (ncRNAs) and their pathophysiological role in a wide range of disease …

Celecoxib nanocrystal-loaded dissolving microneedles with highly efficient for osteoarthritis treatment

Q Wang, X Yang, X Gu, F Wei, W Cao, L Zheng… - International Journal of …, 2022 - Elsevier
Osteoarthritis (OA) is a prevalent degenerative disease that has a significant impact on
patients' lives. Celecoxib (CXB) is now primarily used to treat OA with oral dosing. CXB's …

Therapeutic potential of POU3F3, a novel long non-coding RNA, alleviates the pathogenesis of osteoarthritis by regulating the miR-29a-3p/FOXO3 Axis

M Shi, M Sun, C Wang, Y Shen, Y Wang… - Current Gene …, 2022 - ingentaconnect.com
Background: Osteoarthritis (OA) is the predominant threat to the health of the elderly, and it
is crucial to understand the molecular pathogenetic mechanisms involved in it. This study …

Overview of anti-inflammatory and anti-nociceptive effects of polyphenols to halt osteoarthritis: from preclinical studies to new clinical insights

L Gambari, A Cellamare, F Grassi, B Grigolo… - International Journal of …, 2022 - mdpi.com
Knee osteoarthritis (OA) is one of the most multifactorial joint disorders in adults. It is
characterized by degenerative and inflammatory processes that are responsible for joint …

[引用][C] 滑膜间充质干细胞外泌体源性miR-376b-3p 靶向MYC 抑制骨关节炎进展

牛学刚, 刘朝旭, 刘一帆 - 中国免疫学杂志